| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.35 | 0.0001 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.33 | 6e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.28 | 0.0003 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.26 | 6e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.25 | 9e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.24 | 6e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.23 | 1e-06 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.0004 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.23 | 0.02 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.23 | 0.001 |